Business Breakdowns

Hydreight Technologies (NURS.V/HYDTF): The Mobile Healthcare and Telemedicine Innovator

A Rapidly Growing Healthcare Company

By Adam Wilk · Nov 6, 2025 · 2 min read min read
Hydreight Technologies (NURS.V/HYDTF): The Mobile Healthcare and Telemedicine Innovator

Hydreight Technologies (NURS.V/HYDTF) is a 50-state mobile healthcare and telemedicine company and one of the fastest-growing in North America. Hydreight has grown rapidly from ~C$1mm in adj. revenue in 2020 to over C$22mm during 2024, exclusively through its nurse network and white-label solutions verticals. It has already onboarded 3,000+ nurses, with significant improvement in new business partner sign-ups expected going forward.

Beyond its legacy verticals, NURS’s newly launched D2C VSDHOne platform is expected to geometrically scale recurring-type revenues beginning in 3Q25. Already ahead of schedule, the platform has sold 400+ licenses, targeting 1,000 by year-end. Existing partners are already generating more than 100k monthly orders, with the pipeline being enough to hit the 1.3mm+ full-year order target, even before factoring in its expanding catalog of recurring medications and new partnerships not yet included in guidance. Hydreight now holds its strongest cash position in its history and is fully funded to pursue bold strategic moves if needed. https://hydreight.com

In this discussion, Charles Hutchison and I have a conversation with CEO Shane Madden and Board Chair Shafin Diamond of Hydreight Technologies (NURS.V/HYDTF). You can follow the ongoing discussion on Hydreight Technologies on our community here.

Interact and learn with 250+ of the best microcap investors on the planet:

Join Us

You can listen/watch this business breakdowns on SpotifyApple Podcast, and YouTube below:

Disclaimer: All content in this newsletter is for discussion, education, entertainment, and illustrative purposes only and SHOULD NOT be construed as professional financial advice, solicitation, or recommendation to buy or sell any securities, notwithstanding anything stated on this newsletter and MicroCapClub.com. There are risks associated with investing in securities. Loss of principal is possible. Past performance is not a predictor of future investment performance. Ian Cassel and MicroCapClub.com are not responsible for investment actions taken by viewers. Should you need such advice, consult a licensed financial advisor, legal advisor, or tax advisor. You agree to verify all information yourself before investing. Any past performance discussed on MicroCapClub.com is no guarantee of future results. Investing involves risk and possible loss of principal capital; please seek advice from a licensed professional. All views expressed are personal opinions as of the date of publication and are subject to change without the responsibility to update views. No guarantee is given regarding the accuracy of the information. FULL DISCLAIMER and TERMS OF USE

Free · No Spam · Unsubscribe Anytime

Get New Posts In Your Inbox

Educational articles and microcap insights from full-time investors.

Check your inbox to confirm your subscription. Please enter a valid email address.
Join 30,000+ investors · Free forever · Unsubscribe anytime
LATEST POSTS

Keep Reading MicroCap Insights

View All →